Caricamento...
Acute progression of aspergillosis in a patient with lung cancer receiving nivolumab
A 65‐year‐old man with chronic progressive pulmonary aspergillosis (CPPA) was admitted for the treatment of lung adenocarcinoma while receiving an immune checkpoint inhibitor, nivolumab. The tumour responded well to the therapy, but the cavity of CPPA became large in contrast to the tumour after 20...
Salvato in:
| Pubblicato in: | Respirol Case Rep |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley & Sons, Ltd
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5756713/ https://ncbi.nlm.nih.gov/pubmed/29321933 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rcr2.289 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|